ZAQS.ORG

Thursday, February 19, 2026 12:06 AM ET

CNBC - Health

FDA chief warns U.S. is losing ground to China in early drug development, calls for reforms

8 hours ago

FDA agrees to review Moderna's mRNA flu vaccine application in a reversal

12 hours ago

FDA chief Marty Makary says more drugs should be available over the counter

12 hours ago

Danaher is tapping the M&A well yet again. But we might have had enough

1 day ago

French prosecutors investigate Nestle, Danone over contaminated baby formula

1 day ago

Novo Nordisk faces a defining year in the obesity drug market

2 days ago

How largest health-care education company in U.S. is tackling growing jobs gap

7 days ago

Novo CEO sees 15 million patient opportunity in Medicare obesity coverage

7 days ago

Moderna says FDA refuses to review its application for experimental flu shot

8 days ago

CVS tops quarterly estimates, reaffirms profit outlook as turnaround takes hold

8 days ago

Florida law models what genetic disease testing could be

8 days ago

FDA says Novo Nordisk's TV ad for obesity pill includes misleading claims

8 days ago

Novo Nordisk sues Hims & Hers over copycat versions of Wegovy pill, injections

9 days ago

Hims & Hers stops offering weight loss pill after threats of legal action

9 days ago

Healthy Returns: Pfizer execs chart out obesity drug strategy

11 days ago

White House launches direct-to-consumer drug site TrumpRx. Here's what to know

13 days ago

Eli Lilly sees GLP-1 growth accelerating as Novo Nordisk braces for a decline

13 days ago

Eli Lilly blows past quarterly estimates, posts strong outlook as GLP-1 sales soar

14 days ago

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

15 days ago

Pfizer beats quarterly estimates despite Covid product decline, reaffirms outlook

15 days ago

Merck tops quarterly estimates, posts modest outlook as generic competition looms

15 days ago

Eli Lilly CEO: Medicare coverage of obesity drugs could support pill launch

15 days ago

Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs

19 days ago

As ACA subsidies expire, health costs emerge as top economic worry for voters: survey

19 days ago

Breakthrough drug helps 11-year-old battle rare neurological gene mutation

19 days ago

Healthy Returns: 15 drugs added to Medicare price negotiations

19 days ago

Danaher stock fails to rise on solid earnings — leading us to question what's next

21 days ago

UnitedHealth posts earnings beat, soft revenue guidance as insurer plots turnaround

21 days ago

Next up in weight loss drugs: More pills, easier access and drug combinations

22 days ago

Healthy Returns: Structure Therapeutics CEO on obesity pills, future of GLP-1s

26 days ago

Amazon launches AI health-care tool for One Medical members

28 days ago

OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion

28 days ago

Another alliance of health care and AI signals why pharma stocks could be back

28 days ago

Drug pricing, patent losses, deals: What pharma execs see ahead in the industry

29 days ago